CCCC
Price
$2.10
Change
-$0.02 (-0.94%)
Updated
Aug 4 closing price
Capitalization
149.11M
One day until earnings call
SYRE
Price
$16.16
Change
-$0.10 (-0.62%)
Updated
Aug 4 closing price
Capitalization
975.31M
93 days until earnings call
Interact to see
Advertisement

CCCC vs SYRE

Header iconCCCC vs SYRE Comparison
Open Charts CCCC vs SYREBanner chart's image
C4 Therapeutics
Price$2.10
Change-$0.02 (-0.94%)
Volume$1.24M
Capitalization149.11M
Spyre Therapeutics
Price$16.16
Change-$0.10 (-0.62%)
Volume$728.92K
Capitalization975.31M
CCCC vs SYRE Comparison Chart in %
Loading...
CCCC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SYRE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CCCC vs. SYRE commentary
Aug 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CCCC is a Hold and SYRE is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 05, 2025
Stock price -- (CCCC: $2.10 vs. SYRE: $16.16)
Brand notoriety: CCCC and SYRE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CCCC: 87% vs. SYRE: 120%
Market capitalization -- CCCC: $149.11M vs. SYRE: $975.31M
CCCC [@Biotechnology] is valued at $149.11M. SYRE’s [@Biotechnology] market capitalization is $975.31M. The market cap for tickers in the [@Biotechnology] industry ranges from $213.02B to $0. The average market capitalization across the [@Biotechnology] industry is $2.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CCCC’s FA Score shows that 0 FA rating(s) are green whileSYRE’s FA Score has 0 green FA rating(s).

  • CCCC’s FA Score: 0 green, 5 red.
  • SYRE’s FA Score: 0 green, 5 red.
According to our system of comparison, CCCC is a better buy in the long-term than SYRE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CCCC’s TA Score shows that 5 TA indicator(s) are bullish while SYRE’s TA Score has 3 bullish TA indicator(s).

  • CCCC’s TA Score: 5 bullish, 5 bearish.
  • SYRE’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, CCCC is a better buy in the short-term than SYRE.

Price Growth

CCCC (@Biotechnology) experienced а -3.67% price change this week, while SYRE (@Biotechnology) price change was -4.83% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.94%. For the same industry, the average monthly price growth was +14.50%, and the average quarterly price growth was +10.52%.

Reported Earning Dates

CCCC is expected to report earnings on Oct 30, 2025.

SYRE is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (-2.94% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SYRE($975M) has a higher market cap than CCCC($149M). SYRE YTD gains are higher at: -30.584 vs. CCCC (-41.667). CCCC has higher annual earnings (EBITDA): -102.74M vs. SYRE (-214.36M). SYRE has more cash in the bank: 565M vs. CCCC (215M). SYRE has less debt than CCCC: SYRE (0) vs CCCC (64.4M). CCCC has higher revenues than SYRE: CCCC (39.8M) vs SYRE (0).
CCCCSYRECCCC / SYRE
Capitalization149M975M15%
EBITDA-102.74M-214.36M48%
Gain YTD-41.667-30.584136%
P/E RatioN/A1.72-
Revenue39.8M0-
Total Cash215M565M38%
Total Debt64.4M0-
FUNDAMENTALS RATINGS
SYRE: Fundamental Ratings
SYRE
OUTLOOK RATING
1..100
69
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
62
P/E GROWTH RATING
1..100
83
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CCCCSYRE
RSI
ODDS (%)
Bearish Trend 1 day ago
77%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
80%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
88%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
82%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
87%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
84%
Advances
ODDS (%)
Bullish Trend 19 days ago
83%
Bullish Trend 14 days ago
85%
Declines
ODDS (%)
Bearish Trend 6 days ago
89%
Bearish Trend 1 day ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
75%
Bullish Trend 1 day ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
CCCC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SYRE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PGINF4.16N/A
N/A
Prestige International Inc.
FCSUF0.12N/A
N/A
Focus Minerals Ltd.
SWSDF1069.31N/A
N/A
Swiss Life Holding
PCCWY6.85-0.65
-8.67%
PCCW Limited
CSOL0.01N/A
-18.92%
China Solar & Clean Energy Solutions, Inc.

CCCC and

Correlation & Price change

A.I.dvisor indicates that over the last year, CCCC has been loosely correlated with BEAM. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if CCCC jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CCCC
1D Price
Change %
CCCC100%
-0.94%
BEAM - CCCC
53%
Loosely correlated
+1.54%
CRBU - CCCC
51%
Loosely correlated
+7.69%
IDYA - CCCC
50%
Loosely correlated
+3.09%
KYMR - CCCC
50%
Loosely correlated
+1.63%
SYRE - CCCC
50%
Loosely correlated
-0.62%
More

SYRE and

Correlation & Price change

A.I.dvisor indicates that over the last year, SYRE has been loosely correlated with IDYA. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if SYRE jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SYRE
1D Price
Change %
SYRE100%
-0.62%
IDYA - SYRE
60%
Loosely correlated
+3.09%
CGON - SYRE
58%
Loosely correlated
-0.84%
BEAM - SYRE
58%
Loosely correlated
+1.54%
XNCR - SYRE
57%
Loosely correlated
-0.38%
IMNM - SYRE
55%
Loosely correlated
+3.40%
More